Full Text
Abstract
Textbook for students in higher education and in additional professional education
The textbook is used for classroom studies and independent work of students in the study of prevention and treatment of venous thromboembolic complications in patients with malignant tumors. The content covers the main issues of determin- ing the risk of venous thromboembolic complications and methods of their prevention and treatment in patients with locally advanced and metastatic malignant tumors. The textbook is intended for students in higher education (graduate students, residents, interns, students) and in additional professional education (students of advanced training cycles). The textbook was approved as educating manual by the Scientific Council of NMRC of Oncology n. a. N. N. Petrov HM of RF (protocol No 10 from 09.27.2016).
REFERENCES
1. Russian clinical guidelines for the prevention and treatment of ve- nous thromboembolic complications in cancer patients. [Rossijskie klinicheskie rekomendacii po profilaktike i lecheniyu venoznyh tromboembolicheskih oslozhnenij u onkologicheskih pacientov]. 2012 (in Russ.). URL: http://www.phlebounion.ru/db.img/vte_ in_oncology_final_04.05.2011.pdf.
2. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical Prac- tice Guideline Update. J Clin Oncol. 2013;31(17):2189–204.
3. Mandala M., Falanga A., Roila F. Group EGW. Management of ve- nous thromboembolism (VTE) in cancer patients: ESMO Clin- ical Practice Guidelines. Ann Oncol. 2011;22(Suppl 6):vi85–92.
4. Madzhuga A.V., Somonova O.V., Elizarova A.L., Astakhova V.M. DIC in oncology. [DVS-sindrom v onkologii]. Materia Medica. 1997;1(13):45–52 (in Russ.).
5. Russian Consensus on the prevention of postoperative venous thromboembolic complications. [Rossijskij Konsensus po pro- filaktike posleoperacionnyh venoznyh tromboembolicheskih os- lozhnenij]. Moskva: Medicina, 2000. 20 s (in Russ.).
6. Saveliev V.S., Yablokov Yu.G., Kirienko A.I. Pulmonary embolism. [Tromboemboliya legochnoj arterii]. Moskva: Medicina, 1979. 264 s (in Russ.).
7. Agnelli G. Venous Thromboembolism and cancer: two way clini- cal association. Thromb Haemost. 1997;78(1):117–20.
8. Allan A., Williams J.T., Bolton J.P., LeQuesne L.P. The use of grad- uated compression stockings in the prevention ofpostoperative deep vein thrombosis. Brit J Surg. 1983;70:172–4.
9. Bergqvist D., Burmark U.S., Flordal P.A. et al. Low molecular weight heparin started before surgery as prophylaxis against deep veine thrombosis: 2500 versus 5000 XaI units in 2070 patients. Brit J Surg. 1995;82:496–501.
10. Chahinian A.P., Ware J.H., Zimmer U.N. Update on anticoagu- lation with warfarin and alternating chemotherapy in extensive small cell carcinoma of the lung (SCCL). Proc Am Soc Clin On- col. 1985;4:191.
11. Kucher N., Koo S., Quiroz R. et al. Electronic Alerts to Prevent Venous Thromboembolism among Hospitalized Patients. N Engl J Med. 2005;352:969–77.
12. Khorana A.A., Kuderer N.M., Culakova E. et al. Development and validation of a predictive model for chemotherapy-associ- ated thrombosis. Blood. 2008;111(10):4902–7.
13. Bergqvist В., Agnelli G., Cohen A.T. et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Eng J Med. 2002;346:975–80.
14. ENOXACAN Study Group «Efficacy and safety of Enoxaparin ver- sus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double blind randomized multicentre trial with venographic assessment». Brit J Surg. 1997;84:1099–103.
15. FalangaA.,BarbuiT.,RicklesF.R.,LevineM.N.Guidelinesforclot- ting studies in cancer patients. Thromb Haemost. 1993;70:540–2. 16. Gallus A.S. Prevention of post operative deep leg vein thrombosis in patients with cancer. Thromb Haemost. 1997;78:126–32. 17. Gallus A., Cade J., Ockelford P. et al. Orgaran or heparin for pre- vention of venous thrombosis after elective surgery for malig- nant disease? A double blind randomized multicentre comparison. Thromb Haemot. 1993;70:562–7.
18. Green D., Hull R.D., Brant R., Pineo G.F. Lower mortality in cancer patients treated with low molecular weight versus standard heparin. Lancet. 1992;339(8804):1476.
19. Green K.B., Silverstain R.L. Hypercoagulobility in cancer. Hematol Oncol Clin North Am. 1996;125:1–7.
20. Hillen H.F. Thrombosis in cancer patients. Ann Oncol. 2000;11(Suppl 3):273–6.
21. Kakkar V.V., Howe S.T., Nicolaides A.N. et al. Deep vein thrombosis of the leg: Is there a «high risk» group. Amer J Surg. 1970;120:527–30.
22. Kakkar V.J., Kohen A.T., Edmondson R.A. et al. Low molecular weight vs standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet. 1993;341(8840):259– 65.
23. Kakkar A.K., Williamson R.C.N. Prevention of venous thromboembolism in cancer patients. Semin Thromb Hemost. 1999;25:239– 43.
24. Levine M.N. Prevention of thrombotic disorders in cancer patients, undergoing chemotherapy. Thromb Haemost. 1997;78:133–6. 25. Levine M.N., Lee A.Y. Treatment of venous thromboembolism in cancer patients. Semin Thromb Haemost. 1999;25:245–9.
26. Luzzato G., Schafer A.L. The prethrombotic state in cancer. Semin Oncol. 1990;17:147–59.
27. Prandoni P. Antithrombotic strategies in patients with cancer. Thromb Haemost. 1997;78(1):141–4.
28. RasmussenM.C.,Wille-JorgensenP.,JorgensenL.N.Postoperative fatal pulmonary embolism in a general surgical department. Am J Surg. 1995;169:214–6.
29. Roberts V.C., Cotton L.T. Prevention of postoperative deep vein thrombosis in patients with malignant disease. BMJ. 1974;1:358–60.
30. Rosenberg I.L., Evans M., Pollock A.V. Prophylaxis of postopera-
tive leg vein thrombosis with low dose subcutaneous heparin or peroperative calf muscle stimulation: a controlled clinical trial. BMJ. 1975;1:649–51.
31. Samama Ch.M., Samama M.M. Prevention of venous thrombo- embolism. Congress of European Society of Anaesthesiology. Am- sterdam, 1999. 39–43.
32. The European Fraxiparin Study Group (EFSG). Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. Br J Surg. 1988;75(11):1058–63.